Peroxiredoxin Overexpression in MCF-7 Breast Cancer Cells and Regulation by Cell Proliferation and Oxidative Stress

REFERENCES

• Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine, 3rd edition. New York: Oxford University Press, 1999.
   Google Scholar
• Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem J 2007;401:1–11.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006;160:1–40.
   PubMed Web of Science ®Google Scholar
• Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002;7(3):123–130.
   PubMed Web of Science ®Google Scholar
• Hofmann B, Hecht HJ, Flohe L. Peroxiredoxins. Biol Chem 2002;383(3–4):347–364.
   PubMed Web of Science ®Google Scholar
• Wood ZA, Schröder E, Harris JR, Poole LB. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003;28(1):32–40.
   PubMed Web of Science ®Google Scholar
• Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005;7(5):768–777.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38: 1543–1552.
   PubMed Web of Science ®Google Scholar
• Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal 1999;1(4):385–402.
   PubMed Web of Science ®Google Scholar
• Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 2001;21(3B):2085–2090.
   PubMed Web of Science ®Google Scholar
• Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002;196(3):316–323.
   PubMed Web of Science ®Google Scholar
• Karihtala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003;15(9):3418–3424.
   Google Scholar
• Kinnula VL, Paakko P, Soini Y. Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett 2004;569(1–3):1–6.
   PubMed Web of Science ®Google Scholar
• Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M. Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer 2004;111(4):514–521.
   PubMed Web of Science ®Google Scholar
• Quan C, Cha EJ, Lee HL, Han KH, Lee KM, Kim WJ. Enhanced expression of peroxiredoxin I. and V. I. correlates with development recurrence and progression of human bladder cancer. J Urol 2006;175(4):1512–1516.
   PubMed Web of Science ®Google Scholar
• Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007;9(6): R76.
   PubMed Web of Science ®Google Scholar
• Basu A, Banerjee H, Rojas H, Martinez SR, Roy S SZ, Lilly MB, De León, M, Casiano CA. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 2011;71:755–765.
   PubMed Web of Science ®Google Scholar
• Maxwell GL, Hood BL, Day R, Chandran U, Kirchner D, Kolli VS, Bateman NW, Allard J, Miller C, Sun M, Flint MS, Zahn C, Oliver J, Banerjee S, Litzi T, Parwani A, Sandburg G, Rose S, Becich MJ, Berchuck A, Kohn E, Risinger JI, Conrads TP. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation. Gynecol Oncol 2011;121(3):586–594.
   PubMed Web of Science ®Google Scholar
• Berggren MI, Husbeck B, Samulitis B, Baker AF, Gallegos A, Powis G. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys 2001;392(1):103–109.
   PubMed Web of Science ®Google Scholar
• Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res 2001;21(2A):1129–1133.
   PubMed Web of Science ®Google Scholar
• Husbeck B, Berggren MI, Powis G. DNA microarray reveals increased expression of thioredoxin peroxidase in thioredoxin-1 transfected cells and its functional consequences. Adv Exp Med Biol 2001;500:157–168.
   PubMed Web of Science ®Google Scholar
• Shen C, Nathan C. Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells. Mol Med 2002;8(2):95–102.
   PubMed Web of Science ®Google Scholar
• Butzke D, Machuy N, Thiede B, Hurwitz R, Goedert S, Rudel T. Hydrogen peroxide produced by Aplysia ink toxin kills tumor cells independent of apoptosis via peroxiredoxin I sensitive pathways. Cell Death Differ 2004;11(6):608–617.
   PubMed Web of Science ®Google Scholar
• Bae JY, Ahn SJ, Han W, Noh DYJ. Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines. Cell Biochem 2007;101(4):1038–1045.
   PubMed Web of Science ®Google Scholar
• Neumann CA, Fang Q. Are peroxiredoxins tumor suppressors? Curr Opin Pharm 2007;7(4):375–380.
   PubMed Web of Science ®Google Scholar
• Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Radic Biol Med 2008;45(8):1178–1189.
   PubMed Web of Science ®Google Scholar
• Demasi AP, Furuse C, Soares AB, Altemani A, Araújo VC. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Hum Pathol 2009;40(3):390–397.
   PubMed Web of Science ®Google Scholar
• Ishii T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, Yamamoto M. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 2000;275(21):16023–16029.
   PubMed Web of Science ®Google Scholar
• Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Ono M, Kuwano M, Naito S, Sasaguri Y, Kohno K. Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci 2008;99(10):1950–1959.
   PubMed Web of Science ®Google Scholar
• Baraibar MA, Hyzewicz J, Rogowska-Wrzesinska A, Ladouce R, Roepstorff P, Mouly V, Friguet B. Oxidative stress-induced proteome alterations target different cellular pathways in human myoblasts. Free Radic Biol Med 2011;51(8): 1522–1532.
   PubMed Web of Science ®Google Scholar
• Goncalves K, Sullivan K, Phelan S. Differential expression and function of peroxiredoxin 1 and peroxiredoxin 6 in cancerous MCF-7 and noncancerous MCF-10A breast epithelial cells. Cancer Invest 2012;30(1):38–47.
   PubMed Web of Science ®Google Scholar
• Park KJ, Kim YJ, Kim J, Kim SM, Lee SY, Bae JW, Hwang KK, Kim DW, Cho MC. Protective effects of peroxiredoxin on hydrogen peroxide induced oxidative stress and apoptosis in cardiomyocytes. Korean Circ J 2012;42(1):23–32.
   PubMedGoogle Scholar
• Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2ΔΔCT method. Methods Enzymol 2001;25:402–408.
   Web of Science ®Google Scholar
• Ho JN, Lee SB, Lee SS, Yoon SH, Kang GY, Hwang SG, Um HD. Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells. Mol Cancer Ther 2010;9(4):825–832.
   PubMed Web of Science ®Google Scholar
• Cha MK, Suh KH, Kim IH. Overexpression of peroxiredoxin I and thioredoxin 1 in human breast carcinoma. J Exp Clin Cancer Res 2009;28:93–105.
   PubMed Web of Science ®Google Scholar
• Chua PJ, Lee EH, Yu Y, Yip GW, Tan PH, Bay BH. Silencing the peroxiredoxin III gene inhibits cell proliferation in breast cancer. Int J Oncol 2010;36(2):359–364.
   PubMed Web of Science ®Google Scholar
• Lee SU, Rhee M, Min YK, Kim SH. Involvement of peroxiredoxin IV in the 16α-hydroxyestrone-induced proliferation of human MCF-7 breast cancer cells. Cell Biol Int 2008;32(4):401–405.
   PubMed Web of Science ®Google Scholar